Celgene Corporation is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.
Our talent, scientific knowledge and research capabilities help us to deliver access to innovative, disease-altering therapies to those who need them most. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.
Celgene is headquartered in Summit, New Jersey, and employs more than 7,000 people located in more than 60 countries.
For more information, please visit the Company's website at www.celgene.com.
More than 2.3 million people around the world live with multiple sclerosis. Celgene is focused on continuing to advance research in multiple sclerosis. Our teams and an expert in the field share their excitement for what we’re doing now and what lies ahead for this complex disease and global community.
Pancreatic cancer touches the lives of more people than you think, including some of our own. Our employees’ personal connections to pancreatic cancer give them the drive and passion needed in the fight against this disease. We are working every day to find solutions and to improve the lives of those affected by pancreatic cancer because we know #PatientsAreWaiting
Medical innovation is a virtuous cycle that relies on investments from all stakeholders, patient access to treatment, and our collective commitment. By working together, we can continue to fuel innovation and change patients’ lives.
Since its inception, Celgene Corporation has devoted itself to creating medications that improve the quality of life and prolong the life expectancy for people who suffer from chronic disease. The company conducts multiple clinical trials each year and has proved extraordinarily successful at obtaining FDA and EMA approval for its various products. One of its drugs, Revlimid (generic name lenalidomide) requires such special handling that it has its own dedicated pharmacy (RevAssist) to ensure proper treatment for patients. Many of its efforts focus on multiple mylenoma, a rare form of bone marrow cancer that can cause extreme chronic pain. Celgene Corporation also creates drugs as alternatives for patients whose prior therapies proved unsuccessful.
Employees at Celgene Corporation have access to a wide range of benefits, including insurance, retirement plans, and paid vacation. The company is devoted to promoting work-life balance among its work force, which means that employees are encouraged to maintain active personal lives outside the office so they can devote more energy and effort into their work when they come into the office or lab.
Employees report that they are satisfied with the benefits that Celgene Corporation offers. They also praise the stock options programs, knowledgeable coworkers, generous bonuses, and "small company culture." Employees report that superiors encourage collaboration and reward hard work. – less